Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2005, Volume 29, Issue 2

Extrusion-spheronization and pellet compression are effective means of developing first-order kinetic, controlled-release drug delivery systems of azithromycin (AZI). The authors prepared, evaluated, and optimized AZI formulations and assessed the stability of the selected formulation under accelerated storage conditions.

Related Content:

Drug DeliveryFormulationSolid/Semi-Solid DosageManufacturingDevelopmentDosage FormsPharmaceutical Technology-02-02-2005
With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs
Using Continuous Processes and Automation to Remove Contamination Risk
Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia